Cytokinetics Inc (NASDAQ: CYTK) flaunted slowness of -3.21% at $63.32, as the Stock market unbolted on Thursday, before settling in for the price of $65.42 at the close. Taking a more long-term approach, CYTK posted a 52-week range of $29.31-$70.98.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -20.02%. Meanwhile, its Annual Earning per share during the time was -20.02%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -20.65%. This publicly-traded company’s shares outstanding now amounts to $122.12 million, simultaneously with a float of $119.88 million. The organization now has a market capitalization sitting at $7.74 billion. At the time of writing, stock’s 50-day Moving Average stood at $63.57, while the 200-day Moving Average is $46.53.
Cytokinetics Inc (CYTK) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Cytokinetics Inc industry. Cytokinetics Inc’s current insider ownership accounts for 1.95%, in contrast to 115.70% institutional ownership. According to the most recent insider trade that took place on Jan 05 ’26, this organization’s EVP, Chief Commercial Officer sold 15,000 shares at the rate of 60.28, making the entire transaction reach 904,200 in total value, affecting insider ownership by 50,440. Preceding that transaction, on Jan 02 ’26, Company’s EVP, Chief Commercial Officer sold 1,798 for 62.62, making the whole transaction’s value amount to 112,585. This particular insider is now the holder of 50,440 in total.
Cytokinetics Inc (CYTK) Earnings and Revenue Records
Cytokinetics Inc’s EPS decrease for this current 12-month fiscal period is -20.65% and is forecasted to reach -5.76 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 8.71% through the next 5 years, which can be compared against the -20.02% growth it accomplished over the previous five years trading on the market.
Cytokinetics Inc (NASDAQ: CYTK) Trading Performance Indicators
Let’s observe the current performance indicators for Cytokinetics Inc (CYTK). It’s Quick Ratio in the last reported quarter now stands at 6.88. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 88.77.
In the same vein, CYTK’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -6.31, a figure that is expected to reach -1.55 in the next quarter, and analysts are predicting that it will be -5.76 at the market close of one year from today.
Technical Analysis of Cytokinetics Inc (CYTK)
Now, what If we examine the latest scores posted by [Cytokinetics Inc, CYTK]. During the last 5-days, its volume was better the volume of 2.12 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 77.35% While, its Average True Range was 50.50.
Raw Stochastic average of Cytokinetics Inc (CYTK) in the period of the previous 100 days is set at 78.58%, which indicates a major rise in contrast to 36.85% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 2.94 that was higher than 2.52 volatility it exhibited in the past 100-days period.
